Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naveh Tov

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Chest|May 13, 2003
Pulmonary hypertension in patients with end-stage renal diseaseMordechai Yigla, Farid Nakhoul, Anat Sabag, et al.
Sleep Medicine|July 20, 2007
Long-lasting sleep patterns of adult patients with minor traumatic brain injury (mTBI) and non-mTBI subjectsShaul Schreiber, Gabriel Barkai, Tamar Gur-Hartman, et al.
Cellular Immunology|August 16, 2020
Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of actionRonen Schuster, Noa Motola-Kalay, Boris M Baranovski, et al.
ERJ Open Research|January 15, 2025
Inhaled alpha-1 antitrypsin (AAT) restores lower respiratory tract protease-antiprotease homoeostasis and reduces inflammation in AAT-deficient individuals: a randomised phase 2 studyMark Brantly, James Stocks, Jorge Lascano, et al.
The European Respiratory Journal|August 31, 2019
Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPDJan Stolk, Naveh Tov, Kenneth R Chapman, et al.
International Journal of Molecular Sciences|December 5, 2019
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia<sup>®</sup>) in the Treatment of Recent-Onset Type 1 DiabetesYael Lebenthal, Avivit Brener, Eli Hershkovitz, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Chest|May 13, 2003
Pulmonary hypertension in patients with end-stage renal diseaseMordechai Yigla, Farid Nakhoul, Anat Sabag, et al.
Sleep Medicine|July 20, 2007
Long-lasting sleep patterns of adult patients with minor traumatic brain injury (mTBI) and non-mTBI subjectsShaul Schreiber, Gabriel Barkai, Tamar Gur-Hartman, et al.
Cellular Immunology|August 16, 2020
Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of actionRonen Schuster, Noa Motola-Kalay, Boris M Baranovski, et al.
ERJ Open Research|January 15, 2025
Inhaled alpha-1 antitrypsin (AAT) restores lower respiratory tract protease-antiprotease homoeostasis and reduces inflammation in AAT-deficient individuals: a randomised phase 2 studyMark Brantly, James Stocks, Jorge Lascano, et al.
The European Respiratory Journal|August 31, 2019
Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPDJan Stolk, Naveh Tov, Kenneth R Chapman, et al.
International Journal of Molecular Sciences|December 5, 2019
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia<sup>®</sup>) in the Treatment of Recent-Onset Type 1 DiabetesYael Lebenthal, Avivit Brener, Eli Hershkovitz, et al.
Pageof 2